Alan Krasner, MD (he/him/his)

Chief Endocrinologist
Crinetics Pharmaceuticals, Inc.
Encinitas, CA, United States

Disclosure information not submitted.

Presentation(s):

• ORF32-04 - Once Daily Atumelnant (CRN04894) Enables Lowering of Glucocorticoid Doses with Sustained Androgen Reduction in Adults with Congenital Adrenal Hyperplasia

  Sunday, June 14, 2026
  2:10 PM - 2:25 PM CT

• ORF35-04 - BLOCK AND REPLACE' ATUMELNANT (CRN04894) AND PHYSIOLOGIC HYDROCORTISONE REPLACEMENT RAPIDLY CONTROLS HYPERCORTISOLISM IN ACTH-DEPENDENT CUSHING SYNDROME

  Sunday, June 14, 2026
  3:45 PM - 4:00 PM CT